Analyst Consensus ?
ConsensusHold51 ratings
Bullish2549.0%
Neutral2549.0%
Bearish12.0%
Tractor Supply Company · TSCO · FY2024 Q3 · Calendar Q4 2024
Tractor Supply raises FY24 low-end outlook as Allivet expands pet strategy
The quarter supports a cautiously constructive operating case: management raised the low end of FY24 guidance and cited Fusion stores, big-ticket demand, loyalty, and the Allivet acquisition as growth supports. The evidence is not unqualified, with flat comparable sales, pressure in discretionary categories, and weather, commodity, and margin risks still requiring execution.
Reported Before market openNASDAQConsumer Cyclical
$17.41B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.24
Consensus $2.24
EPS surprise
0.0%
Reported versus consensus
Reported revenue
$3.47B
Consensus $3.48B
Revenue surprise
-0.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-6.1%
Event window
SPY move
+0.2%
Same window
Abnormal move
-6.3%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
-0.2%
Up to 20 sessions
TSCOSPY benchmark
Ask FN2 about TSCO FY2024 Q3
Transcript, numbers and history already loaded
Why did TSCO fall 6.1% after beating EPS estimates in FY2024 Q3?What changed in TSCO's guidance and outlook in FY2024 Q3?Give me the bull and bear case for TSCO after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the company reported Q3 results, raised the low end of FY24 guidance, and announced Allivet. Management also emphasized continued Fusion and Garden Center investment, a larger FY25 store-opening and remodel plan, and broader use of AI and machine learning.
Guidance delta
Management raised the low end of FY24 sales and earnings guidance; EPS guidance moved to $10.10-$10.40.
Key takeaways
- Q3 net sales grew 1.6%, while comparable-store sales were down 0.2%.
- Diluted EPS was $2.24, in line with the supplied estimate; revenue was modestly below estimate.
- Allivet adds an online pet-pharmacy capability and can be integrated with Neighbor's Club.
- Fusion remodels, Garden Centers, and big-ticket categories were highlighted as relative strengths.
- Discretionary categories, weather, product mix, and SG&A remain important execution variables.
Management priorities
- Integrate Allivet with the 37 million-member Neighbor's Club
- Continue Fusion remodels and Garden Center expansion
- Open about 90 new stores in FY25 and remodel 175-225 stores annually
- Use AI and machine learning for personalization and supply-chain efficiency
- Support growth through big-ticket product innovation and digital sales
Follow TSCO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$33.42Current
$28Low
$96.85Average
$315High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 23, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Oct 23, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 23, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 23, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 23, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Oct 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 23, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 13, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 28, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 24, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 24, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 17, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 7, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jun 22, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 22, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 30, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jan 22, 2026 |
| Gordon Haskett | Hold | Buy | Downgrade | Jan 8, 2026 |
| Loop Capital | Hold | Hold | Maintain | Jul 25, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Jan 16, 2025 |
| Benchmark | Buy | Buy | Maintain | Oct 28, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Oct 25, 2024 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 13, 2023 |
| Cowen & Co. | Perform | Market Perform | Maintain | Feb 16, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jan 19, 2023 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 12, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Dec 20, 2022 |
| Northcoast Research | Buy | Neutral | Upgrade | Jul 1, 2021 |
| Nomura Instinet | Neutral | Neutral | Maintain | May 27, 2020 |
| Nomura | Neutral | Neutral | Maintain | May 27, 2020 |
| Northcoast | Buy | Neutral | Upgrade | Oct 2, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Jul 16, 2019 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 13, 2018 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Oct 26, 2018 |
| Bank of America | Neutral | Underperform | Upgrade | Oct 26, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bernstein | Outperform | Outperform | Maintain | Feb 27, 2018 |
| Moffett Nathanson | Neutral | Neutral | Maintain | Dec 4, 2017 |
| BMO Capital | Market Perform | Market Perform | Maintain | Sep 27, 2017 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Feb 3, 2017 |
| BTIG Research | Neutral | Buy | Downgrade | Sep 8, 2016 |
| BTIG | Neutral | Buy | Downgrade | Sep 8, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 24, 2014 |
| Avondale Partners | Outperform | Market Outperform | Maintain | May 17, 2013 |
| Feltl & Co. | Hold | Strong Buy | Downgrade | Mar 7, 2013 |
| Bank oferica | Buy | Buy | Maintain | May 3, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $33.42. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | David Bellinger | $31 | $34.73 | -7.2% | Oct 23, 2026 |
| Piper Sandler | Peter Keith | $35 | $34.73 | +4.7% | Oct 23, 2026 |
| Robert W. Baird | Peter Benedict | $40 | $34.73 | +19.7% | Oct 23, 2026 |
| Truist Financial | Scot Ciccarelli | $34 | $34.73 | +1.7% | Oct 22, 2026 |
| Piper Sandler | Analyst unavailable | $33 | $33.16 | -1.3% | Oct 19, 2026 |
| Truist Financial | Scot Ciccarelli | $33 | $33.16 | -1.3% | Oct 19, 2026 |
| Wells Fargo | Analyst unavailable | $36 | $33.16 | +7.7% | Oct 19, 2026 |
| D.A. Davidson | Michael Baker | $36 | $33.3 | +7.7% | Oct 8, 2026 |
| Argus Research | Analyst unavailable | $41 | $32.23 | +22.7% | Jul 28, 2026 |
| Telsey Advisory | Joseph Feldman | $38 | $30.12 | +13.7% | Jul 24, 2026 |
| Mizuho Securities | Analyst unavailable | $28 | $30.13 | -16.2% | Jul 24, 2026 |
| Morgan Stanley | Simeon Gutman | $35 | $30.32 | +4.7% | Jul 24, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $30.32 | -7.2% | Jul 24, 2026 |
| Guggenheim | Analyst unavailable | $40 | $30.32 | +19.7% | Jul 24, 2026 |
| Goldman Sachs | Kate McShane | $38 | $30.32 | +13.7% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $38 | $30.51 | +13.7% | Jul 20, 2026 |
| Raymond James | Bobby Griffin | $40 | $31.01 | +19.7% | Jul 17, 2026 |
| Wolfe Research | Analyst unavailable | $34 | $30.17 | +1.7% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $35 | $30.55 | +4.7% | Jul 15, 2026 |
| Telsey Advisory | Analyst unavailable | $40 | $30.16 | +19.7% | Jul 14, 2026 |
| UBS | Analyst unavailable | $33 | $30.03 | -1.3% | Jul 14, 2026 |
| Barclays | Analyst unavailable | $35 | $30.43 | +4.7% | Jul 13, 2026 |
| Mizuho Securities | Analyst unavailable | $32 | $29.58 | -4.2% | Jul 9, 2026 |
| Evercore ISI | Oliver Wintermantel | $40 | $30.61 | +19.7% | Jul 7, 2026 |
| D.A. Davidson | Michael Baker | $40 | $29.86 | +19.7% | Jun 22, 2026 |
| Piper Sandler | Analyst unavailable | $32 | $30.88 | -4.2% | Jun 16, 2026 |
| Truist Financial | Analyst unavailable | $32 | $30.88 | -4.2% | Jun 16, 2026 |
| Guggenheim | Steven Forbes | $50 | $29.37 | +49.6% | Jun 5, 2026 |
| Piper Sandler | Peter Keith | $36 | $32.31 | +7.7% | May 5, 2026 |
| Guggenheim | Steven Forbes | $60 | $38.96 | +79.5% | Apr 23, 2026 |
| Jefferies | Jonathan Matuszewski | $51 | $39.26 | +52.6% | Apr 21, 2026 |
| Truist Financial | Analyst unavailable | $44 | $39.28 | +31.7% | Apr 21, 2026 |
| Robert W. Baird | Analyst unavailable | $60 | $44.63 | +79.5% | Apr 17, 2026 |
| Wells Fargo | Zachary Fadem | $55 | $45.44 | +64.6% | Apr 14, 2026 |
| UBS | Analyst unavailable | $55 | $51.58 | +64.6% | Jan 30, 2026 |
| D.A. Davidson | Michael Baker | $60 | $50.05 | +79.5% | Jan 30, 2026 |
| Goldman Sachs | Analyst unavailable | $59 | $50.96 | +76.5% | Jan 30, 2026 |
| Mizuho Securities | Analyst unavailable | $58 | $50.96 | +73.5% | Jan 30, 2026 |
| Piper Sandler | Analyst unavailable | $59 | $50.96 | +76.5% | Jan 30, 2026 |
| Wolfe Research | Spencer Hanus | $57 | $50.96 | +70.6% | Jan 30, 2026 |
| Telsey Advisory | Joseph Feldman | $63 | $50.96 | +88.5% | Jan 30, 2026 |
| Evercore ISI | Oliver Wintermantel | $60 | $50.96 | +79.5% | Jan 30, 2026 |
| Stephens | Jeff Lick | $53 | $54.11 | +58.6% | Jan 22, 2026 |
| UBS | Analyst unavailable | $57 | $50.73 | +70.6% | Jan 16, 2026 |
| Truist Financial | Scot Ciccarelli | $55 | $50.73 | +64.6% | Jan 16, 2026 |
| Gordon Haskett Capital Corporation | Analyst unavailable | $50 | $49.89 | +49.6% | Jan 8, 2026 |
| Jefferies | Jonathan Matuszewski | $64 | $52.92 | +91.5% | Nov 24, 2025 |
| Evercore ISI | Oliver Wintermantel | $65 | $53.29 | +94.5% | Nov 5, 2025 |
| D.A. Davidson | Michael Baker | $70 | $56.35 | +109.5% | Oct 24, 2025 |
| Robert W. Baird | Peter Benedict | $67 | $57.52 | +100.5% | Oct 24, 2025 |
| Mizuho Securities | Analyst unavailable | $65 | $56.35 | +94.5% | Oct 24, 2025 |
| Morgan Stanley | Simeon Gutman | $60 | $57.52 | +79.5% | Oct 24, 2025 |
| Wells Fargo | Analyst unavailable | $65 | $56.32 | +94.5% | Oct 23, 2025 |
| Wolfe Research | Spencer Hanus | $70 | $59.1 | +109.5% | Sep 17, 2025 |
| Telsey Advisory | Joseph Feldman | $70 | $59.33 | +109.5% | Jul 25, 2025 |
| UBS | Michael Lasser | $61 | $59.33 | +82.5% | Jul 25, 2025 |
| Telsey Advisory | Analyst unavailable | $60 | $49.92 | +79.5% | Apr 25, 2025 |
| UBS | Analyst unavailable | $54 | $49.92 | +61.6% | Apr 25, 2025 |
| Guggenheim | Analyst unavailable | $55 | $49.92 | +64.6% | Apr 25, 2025 |
| Robert W. Baird | Peter Benedict | $315 | $274.29 | +842.5% | Oct 24, 2024 |
| D.A. Davidson | Michael Baker | $300 | $297.62 | +797.7% | Oct 21, 2024 |
| Robert W. Baird | Peter Benedict | $320 | $302.8 | +857.5% | Oct 17, 2024 |
| Telsey Advisory | Joseph Feldman | $335 | $302.8 | +902.4% | Oct 17, 2024 |
| Piper Sandler | Peter Keith | $332 | $303.37 | +893.4% | Oct 14, 2024 |
| Truist Financial | Scot Ciccarelli | $325 | $303.37 | +872.5% | Oct 14, 2024 |
| Evercore ISI | Oliver Wintermantel | $300 | $294.29 | +797.7% | Oct 3, 2024 |
| Melius Research | Karen Short | $315 | $275.88 | +842.5% | Sep 23, 2024 |
| Wedbush | Seth Basham | $270 | $264.47 | +707.9% | Jul 26, 2024 |
| Telsey Advisory | Joseph Feldman | $300 | $262.52 | +797.7% | Jul 26, 2024 |
| Jefferies | Jonathan Matuszewski | $260 | $257.44 | +678.0% | Jul 25, 2024 |
| Piper Sandler | Peter Keith | $300 | $275.47 | +797.7% | Apr 29, 2024 |
| Evercore ISI | Oliver Wintermantel | $275 | $253.38 | +722.9% | Apr 23, 2024 |
| Telsey Advisory | Joseph Feldman | $275 | $247.35 | +722.9% | Apr 19, 2024 |
| Truist Financial | Scot Ciccarelli | $277 | $258.24 | +728.8% | Apr 2, 2024 |
| Telsey Advisory | Joseph Feldman | $245 | $197.14 | +633.1% | Oct 20, 2023 |
| Raymond James | Bobby Griffin | $235 | $204.84 | +603.2% | Oct 10, 2023 |
| Truist Financial | Scot Ciccarelli | $235 | $205.17 | +603.2% | Oct 5, 2023 |
| Telsey Advisory | Joseph Feldman | $250 | $202.65 | +648.1% | Jul 15, 2022 |
| Truist Financial | Scot Ciccarelli | $266 | $195.3 | +695.9% | Jun 13, 2022 |
| Morgan Stanley | Analyst unavailable | $220 | $205.35 | +558.3% | Apr 25, 2022 |
| Citigroup | Analyst unavailable | $250 | $212.61 | +648.1% | Apr 22, 2022 |
| Piper Sandler | Analyst unavailable | $261 | $219.18 | +681.0% | Apr 22, 2022 |
| Robert W. Baird | Peter Benedict | $250 | $219.18 | +648.1% | Apr 21, 2022 |
| Citigroup | Steven Zaccone | $240 | $214.84 | +618.1% | Jan 30, 2022 |
| Morgan Stanley | Simeon Gutman | $235 | $220.48 | +603.2% | Jan 18, 2022 |
| Truist Financial | Scot Ciccarelli | $270 | $227.93 | +707.9% | Jan 12, 2022 |
| Argus Research | Taylor Conrad | $255 | $235.71 | +663.0% | Dec 30, 2021 |
| D.A. Davidson | Michael Baker | $232 | $235.71 | +594.2% | Dec 30, 2021 |
| Gordon Haskett Capital Corporation | Charles Grom | $240 | $217.2 | +618.1% | Nov 11, 2021 |
| Raymond James | Bobby Griffin | $245 | $206.85 | +633.1% | Oct 22, 2021 |
| Stephens | Daniel Imbro | $241 | $206.85 | +621.1% | Oct 22, 2021 |
| UBS | Michael Lasser | $220 | $206.85 | +558.3% | Oct 22, 2021 |
| Goldman Sachs | Kate McShane | $241 | $206.85 | +621.1% | Oct 22, 2021 |
| Barclays | Karen Short | $215 | $206.85 | +543.3% | Oct 22, 2021 |
| Loop Capital Markets | Anthony Chukumba | $215 | $206.85 | +543.3% | Oct 22, 2021 |
| Guggenheim | Steven Forbes | $230 | $206.85 | +588.2% | Oct 22, 2021 |
| Northcoast Research | Chuck Cerankosky | $220 | $186.12 | +558.3% | Jul 1, 2021 |
| Wedbush | Seth Basham | $190 | $187.11 | +468.5% | Apr 23, 2021 |
Track every rating change on TSCO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTractor Supply Company functions as a prominent retailer, catering to the rural lifestyle demographic throughout the United States. Its extensive product catalog encompasses items crucial for the health, well-being, development, and enclosure of equine, livestock, pets, and small animals. Additionally, it stocks a variety of hardware, truck, towing, and tool supplies. Shoppers can also find seasonal goods like heating solutions, gardening equipment, power tools, novelty gifts, and children's toys, alongside workwear, casual apparel, footwear, and essential maintenance products designed for agricultural and general rural applications.…
Historical context
All TSCO earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DECK Deckers Outdoor Corporation | FY2027 Q2 · Calendar Q4 2026 | +13.4% | -0.2% | Deckers raises FY2027 outlook as HOKA and UGG drive growth |
| PHM PulteGroup, Inc. | FY2026 Q3 · Calendar Q4 2026 | -4.5% | +5.8% | PulteGroup Holds Guidance as Buyer Traffic Slows |
| PKG Packaging Corporation of America | FY2026 Q3 · Calendar Q4 2026 | +3.8% | +4.2% | PCA beats Q3 expectations as Greif synergies offset cost pressure |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the TSCO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-24T15:30:42.663133+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T15:30:42.660364+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.